Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis

Abstract

The combined strategy of gene subtraction and semiquantitative RT-PCR may allow the definition of MO activation patterns during different disease phases (including therapy-induced remission) and the identification of novel MO genes with pathogenetic relevance in RA.